Cephalon volatility flat; shares sell off 7% on clinical trial
Cephalon is recently down $5.37 to $54.24 in pre-open trading. Cephalon Phase IIb/III Cinquil trial did not meet its endpoint. Over all option implied volatility of 35 is near its 26-week average of 34 according to Track Data, suggesting non-directional price movement. :theflyonthewall.com
News For CEPH From The Last 14 Days
Check below for free stories on CEPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
